Which hedge funds own EHC? ENCOMPASS HEALTH CORP, Q2 2026 13F holders
Healthcare · Open on the interactive board
10 of the hedge funds tracked by WhaleCreep disclosed a position in EHC (ENCOMPASS HEALTH CORP) in their Q2 2026 13F filings, worth $519.8m in total. The largest holder by portfolio weight is Avidity Partners at 0.7% of its book. 2 exited: Farallon Capital Management, Tudor Investment.
10tracked managers holding
0opened this quarter
2exited this quarter
Which hedge funds hold EHC? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Avidity Partners | Q2 2026 | 0.7% | $4.2m | 42,000 | 0% | held |
| Davidson Kempner Capital Management | Q2 2026 | 0.2% | $15.3m | 151,267 | 731% | added |
| Holocene Advisors | Q2 2026 | 0.2% | $98.8m | 977,634 | 550% | added |
| Citadel Advisors | Q2 2026 | 0.1% | $259.1m | 2,563,104 | 401% | added |
| Millennium Management | Q2 2026 | 0.1% | $81.4m | 805,717 | 69% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $17.6m | 174,500 | -34% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $38.9m | 384,595 | -32% | reduced |
| Bridgewater Associates | Q2 2026 | 0.0% | $4.1m | 41,016 | -12% | reduced |
| Ancora Advisors | Q2 2026 | 0.0% | $15.8k | 105,258 | 14% | added |
| Marshall Wace | Q2 2026 | 0.0% | $225.1k | 2,227 | -99% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Farallon Capital Management | 0.0% | $290.2k |
| Tudor Investment | 0.2% | $3.0m |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Caxton Associates | Q4 2024 | 0.0% |
How has hedge fund ownership of EHC changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 10 | $519.8m |
| Q1 2026 | 12 | $233.0m |
| Q4 2025 | 8 | $190.5m |
| Q3 2025 | 9 | $189.9m |
| Q2 2025 | 8 | $180.7m |
| Q1 2025 | 7 | $144.8m |
| Q4 2024 | 9 | $152.1m |
| Q3 2024 | 10 | $244.7m |
| Q2 2024 | 8 | $174.0m |
| Q1 2024 | 7 | $144.8m |
| Q4 2023 | 7 | $204.4m |
| Q3 2023 | 8 | $233.6m |
| Q2 2023 | 8 | $240.6m |
| Q1 2023 | 5 | $66.1m |
| Q4 2022 | 8 | $219.5m |
| Q3 2022 | 9 | $356.1m |
Counts every tracked manager that disclosed EHC in that quarter's filing, including managers that have since stopped filing.